Companies: 10,795·Total market cap: $144.5T
Shionogi & Co., Ltd.

Shionogi & Co., Ltd.

SGIOFOTCHealthcare● Active
$17.68
+$0.00(+0.00%)
Market Cap$15.0B
P/E Ratio—
52W High$26
52W Low$14.25
Overview

Shionogi & Co., Ltd. (SGIOF) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

SGIOF · shares outstanding · updated Jun 9, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
850.9M▲ +200.04% YoY Change
FY · as of Mar 31, 2026 · Reported in JPY
vs 283.6M in FY 2025
Diluted Shares Outstanding
851.1M
incl. options, RSUs, convertibles
Dilution Spread
+0.03%
Diluted vs Basic
YoY Change
+200.04%
year-over-year
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-09

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+41.9%
2023 → 2026
5-Year CAGRincreasing
+22.7%
2021 → 2026
10-Year CAGRincreasing
+10.1%
2016 → 2026
ⓘ

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2026Latest
Diluted Shares: 851.1M
850.9M
+200.04%
FY 2025
Diluted Shares: 283.6M
283.6M
-2.28%
FY 2024
Diluted Shares: 290.2M
290.2M
-2.52%
FY 2023
Diluted Shares: 297.8M
297.7M
-1.25%
FY 2022
Diluted Shares: 301.6M
301.5M
-1.62%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs SGIOF
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+194.0%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+185.4%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+109.2%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+82.2%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+6.9%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+5.5%
#7
Shionogi & Co., Ltd.SGIOF
Shionogi & Co., Ltd.YOU
850.9M—

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

Shionogi & Co., Ltd. (SGIOF) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of March 31, 2026, Shionogi & Co., Ltd. reports 850.9M basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

Shionogi & Co., Ltd.'s basic shares outstanding (850.9M) represents currently issued shares. Diluted shares outstanding (851.1M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.03%.

Shares Outstanding vs. Float (Free Float)

Shionogi & Co., Ltd.'s float is — (— of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

ⓘ Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · JPY

About shares outstanding & methodology

Shionogi & Co., Ltd. (SGIOF) shares outstanding history from 2007 to 2026. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

Shionogi & Co., Ltd. shares outstanding for the fiscal year ending March 31, 2026 were 850.9M, a 200.04% increase year-over-year. Shionogi & Co., Ltd. FY 2026 shares outstanding were 850.9M, a +200.04% increase from FY 2025.

Shionogi & Co., Ltd. is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of +10.1% — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.
Market capSplitsEarningsFinancials (Income)Cash on handFree cash flowNet incomePrice history

Frequently asked questions

SGIOF shares outstanding · 4 questions

As of March 31, 2026, Shionogi & Co., Ltd. (SGIOF) has approximately 850.9M basic shares outstanding and 851.1M diluted shares outstanding. This represents a +200.04% year-over-year increase from FY 2025 (283.6M). The increase may reflect equity compensation issuances or secondary offerings.

SGIOF shares outstandinghow many shares does SGIOF haveSGIOF basic shares 2026SGIOF diluted shares

▸ Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Shionogi & Co., Ltd. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-09